Document is current
Any future updates will be listed below
-
Authors
Coley, Nicola http://orcid.org/0000-0002-1671-824X
Coniasse-Brioude, Delphine
Igier, Valérie
Fournier, Tristan
Poulain, Jean-Pierre
Andrieu, Sandrine
,
Andrieu, Sandrine
Coley, Nicola
Gardette, Virginie
Grand, Alain
Igier, Valérie
Brioude, Delphine Coniasse
Sastre, Maria Teresa Munoz
Poulain, Jean Pierre
Fournier, Tristan
Arandjelovic, Christelle
Vellas, Bruno
Oustric, Stephane
Subra, Julie
-
Funding
Funding for this research was provided by:
institut de recherche en santé publique
institut national de prévention et d'éducation pour la santé
- License Information
-
More Information
Article History
Received: 18 June 2021
Accepted: 12 September 2021
First Online: 24 September 2021
Declarations
:
: The MAPT trial protocol, including the ACCEPT sub-study, was approved by the Toulouse ethics committee (CPP SOOM II) and the French Health Authority, and trial participants provided written informed consent.
: Not applicable
: SA reports grants from EU programs, Fondation de l’Avenir, and the AMPA and France Alzheimer Associations; personal fees from Nestlé, Nestec SA, Sanofi, and MSD; and non-financial support from Biogen, Pfizer, and Icon outside the submitted work. The other authors have no competing interests.
